Insider · CIK 0001494386
Eric J Ende
Files at AVDL (AVADEL PHARMACEUTICALS PLC). First filing Jan 14, 2025, latest Jan 14, 2025.
Eric J Ende files SEC Form 4 as director at AVDL (AVADEL PHARMACEUTICALS PLC). Since Jan 14, 2025, Eric J Ende has reported 1 open-market buy worth $235k and 0 open-market sells worth $0, the latest filed on Jan 14, 2025.
A track record needs three past buys with six months of prices behind them; Eric J Ende has 0, so none is measured yet.
The newest scored trade: bought $235k of AVDL on Jan 13, 2025, filed Jan 14, 2025, scored 46 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | AVADEL PHARMACEUTICALS PLC | $235k 30,000 shares | +17% | - |
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Ordinary Shares | -219,905 | $21.00 | $4.6M | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,057 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivative | -60,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivative | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivative | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivative | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivative | -33,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivative | -11,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivative | -11,000 | - | - | 0 | Feb 12, 2026 |
| Jul 29, 2025 | AVDL AVADEL PHARMACEUTICALS PLC | AGrant or award Ordinary Shares | +11,000 | $0.00 | $0 | 219,900 | Jul 31, 2025 |
| Jul 29, 2025 | AVDL AVADEL PHARMACEUTICALS PLC | AGrant or award Stock Option (Right to Buy)derivative | +11,000 | $0.00 | $0 | 11,000 | Jul 31, 2025 |
| Jan 13, 2025 | AVDL AVADEL PHARMACEUTICALS PLC | POpen-market purchase Ordinary Shares | +30,000 | $7.84 | $235k | 208,900 | Jan 14, 2025 |
Questions about Eric J Ende
Answered from the filings on this page, as of the latest one.
Is Eric J Ende buying or selling?
Not in the last 12 months. Eric J Ende's latest open-market trade on SEC Form 4 was bought $235k of AVDL on Jan 13, 2025.
How did Eric J Ende's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Eric J Ende has 0.
Where does Eric J Ende file Form 4?
Eric J Ende has filed Form 4 at AVDL (AVADEL PHARMACEUTICALS PLC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.